2022
DOI: 10.1016/j.trim.2022.101640
|View full text |Cite
|
Sign up to set email alerts
|

An overview of post transplantation events of decellularized scaffolds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 104 publications
0
3
0
Order By: Relevance
“…Ultimately, the findings of the present study complement the current research on animal dECM-derived biomaterials for wound healing and regenerative medicine applications, further proving the importance of exploiting ECM components to achieve bioactivity. Moreover, there are other advantages to using animal derived biomaterials, such as: (i) the low immunogenicity of the product, guaranteed by the decellularization process used, should reduce the risk of rejection after implant [ 36 , 41 ] and, (ii) being a large animal derived food industry by-product, it should be available in large quantities and easily obtainable when compared to cell derived or human sources of dECM [ 35 ]. However, there are still some disadvantages and risks in using these biomaterials.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Ultimately, the findings of the present study complement the current research on animal dECM-derived biomaterials for wound healing and regenerative medicine applications, further proving the importance of exploiting ECM components to achieve bioactivity. Moreover, there are other advantages to using animal derived biomaterials, such as: (i) the low immunogenicity of the product, guaranteed by the decellularization process used, should reduce the risk of rejection after implant [ 36 , 41 ] and, (ii) being a large animal derived food industry by-product, it should be available in large quantities and easily obtainable when compared to cell derived or human sources of dECM [ 35 ]. However, there are still some disadvantages and risks in using these biomaterials.…”
Section: Discussionmentioning
confidence: 99%
“…Their biological advantage is mainly given by their complex structure and composition, which greatly conserves the native ECM, thereby maintaining the ability to support cellular behavior and tissue functions [ 34 , 35 ]. Moreover, these bioactive materials naturally possess both angiogenic and immunomodulatory potential [ 36 , 37 , 38 , 39 ]. This leads not only to a number of applications of decellularized ECM-derived materials in regenerative medicine [ 40 ], but also to the high interest in using them as multi-functional wound dressing [ 14 , 41 , 42 ].…”
Section: Introductionmentioning
confidence: 99%
“…Native cardiac ECM is a promising biomedical material that can be applied to reconstructive surgery, due to its structural and functional resemblance to native tissue [ 7 ]. Additionally, native cardiac ECM has been used as a scaffold for 3D culturing [ 8 , 9 ]. Previous research has shown that injectable biohybrid ECM-based hydrogels promote cardiac tissue regeneration [ 10 ].…”
Section: Introductionmentioning
confidence: 99%